The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells

Annalisa Natalicchio, Federica Tortosa, Rossella Labarbuta, Giuseppina Biondi, Nicola Marrano, Emanuele Carchia, Anna Leonardini, Angelo Cignarelli, Marco Bugliani, Piero Marchetti, Gian Paolo Fadini, Marco Giorgio, Angelo Avogaro, Sebastio Perrini, Luigi Laviola, Francesco Giorgino

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Aims/hypothesis: The role of the redox adaptor protein p66Shc as a potential mediator of saturated fatty acid (FA)-induced beta cell death was investigated. Methods: The effects of the FA palmitate on p66Shc expression were evaluated in human and murine islets and in rat insulin-secreting INS-1E cells. p66Shc expression was also measured in islets from mice fed a high-fat diet (HFD) and from human donors with different BMIs. Cell apoptosis was quantified by two independent assays. The role of p66Shc was investigated using pancreatic islets from p66Shc−/− mice and in INS-1E cells with knockdown of p66Shc or overexpression of wild-type and phosphorylation-defective p66Shc. Production of reactive oxygen species (ROS) was evaluated by the dihydroethidium oxidation method. Results: Palmitate induced a selective increase in p66Shc protein expression and phosphorylation on Ser36 and augmented apoptosis in human and mouse islets and in INS-1E cells. Inhibiting the tumour suppressor protein p53 prevented both the palmitate-induced increase in p66Shc expression and beta cell apoptosis. Palmitate-induced apoptosis was abrogated in islets from p66Shc−/− mice and following p66Shc knockdown in INS-1E cells; by contrast, overexpression of p66Shc, but not that of the phosphorylation-defective p66Shc mutant, enhanced palmitate-induced apoptosis. The pro-apoptotic effects of p66Shc were dependent upon its c-Jun N-terminal kinase-mediated phosphorylation on Ser36 and associated with generation of ROS. p66Shc protein expression and function were also elevated in islets from HFD-fed mice and from obese/overweight cadaveric human donors. Conclusions/interpretation: p53-dependent augmentation of p66Shc expression and function represents a key signalling response contributing to beta cell apoptosis under conditions of lipotoxicity.

Original languageEnglish
Pages (from-to)1260-1271
Number of pages12
JournalDiabetologia
Volume58
Issue number6
DOIs
Publication statusPublished - Jun 1 2015

Fingerprint

Insulin-Secreting Cells
Oxidation-Reduction
Palmitates
Fatty Acids
Apoptosis
Phosphorylation
Proteins
High Fat Diet
Reactive Oxygen Species
Tumor Suppressor Protein p53
Obese Mice
JNK Mitogen-Activated Protein Kinases
Islets of Langerhans
Cell Death
Insulin

Keywords

  • Apoptosis
  • Beta cell
  • Exendin-4
  • JNK
  • p53
  • p66<sup>Shc</sup>
  • Palmitic acid
  • Pancreatic islet

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Natalicchio, A., Tortosa, F., Labarbuta, R., Biondi, G., Marrano, N., Carchia, E., ... Giorgino, F. (2015). The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells. Diabetologia, 58(6), 1260-1271. https://doi.org/10.1007/s00125-015-3563-2

The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells. / Natalicchio, Annalisa; Tortosa, Federica; Labarbuta, Rossella; Biondi, Giuseppina; Marrano, Nicola; Carchia, Emanuele; Leonardini, Anna; Cignarelli, Angelo; Bugliani, Marco; Marchetti, Piero; Fadini, Gian Paolo; Giorgio, Marco; Avogaro, Angelo; Perrini, Sebastio; Laviola, Luigi; Giorgino, Francesco.

In: Diabetologia, Vol. 58, No. 6, 01.06.2015, p. 1260-1271.

Research output: Contribution to journalArticle

Natalicchio, A, Tortosa, F, Labarbuta, R, Biondi, G, Marrano, N, Carchia, E, Leonardini, A, Cignarelli, A, Bugliani, M, Marchetti, P, Fadini, GP, Giorgio, M, Avogaro, A, Perrini, S, Laviola, L & Giorgino, F 2015, 'The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells', Diabetologia, vol. 58, no. 6, pp. 1260-1271. https://doi.org/10.1007/s00125-015-3563-2
Natalicchio, Annalisa ; Tortosa, Federica ; Labarbuta, Rossella ; Biondi, Giuseppina ; Marrano, Nicola ; Carchia, Emanuele ; Leonardini, Anna ; Cignarelli, Angelo ; Bugliani, Marco ; Marchetti, Piero ; Fadini, Gian Paolo ; Giorgio, Marco ; Avogaro, Angelo ; Perrini, Sebastio ; Laviola, Luigi ; Giorgino, Francesco. / The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells. In: Diabetologia. 2015 ; Vol. 58, No. 6. pp. 1260-1271.
@article{b331f66a1b68421a9b3f6cba6edef3dd,
title = "The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells",
abstract = "Aims/hypothesis: The role of the redox adaptor protein p66Shc as a potential mediator of saturated fatty acid (FA)-induced beta cell death was investigated. Methods: The effects of the FA palmitate on p66Shc expression were evaluated in human and murine islets and in rat insulin-secreting INS-1E cells. p66Shc expression was also measured in islets from mice fed a high-fat diet (HFD) and from human donors with different BMIs. Cell apoptosis was quantified by two independent assays. The role of p66Shc was investigated using pancreatic islets from p66Shc−/− mice and in INS-1E cells with knockdown of p66Shc or overexpression of wild-type and phosphorylation-defective p66Shc. Production of reactive oxygen species (ROS) was evaluated by the dihydroethidium oxidation method. Results: Palmitate induced a selective increase in p66Shc protein expression and phosphorylation on Ser36 and augmented apoptosis in human and mouse islets and in INS-1E cells. Inhibiting the tumour suppressor protein p53 prevented both the palmitate-induced increase in p66Shc expression and beta cell apoptosis. Palmitate-induced apoptosis was abrogated in islets from p66Shc−/− mice and following p66Shc knockdown in INS-1E cells; by contrast, overexpression of p66Shc, but not that of the phosphorylation-defective p66Shc mutant, enhanced palmitate-induced apoptosis. The pro-apoptotic effects of p66Shc were dependent upon its c-Jun N-terminal kinase-mediated phosphorylation on Ser36 and associated with generation of ROS. p66Shc protein expression and function were also elevated in islets from HFD-fed mice and from obese/overweight cadaveric human donors. Conclusions/interpretation: p53-dependent augmentation of p66Shc expression and function represents a key signalling response contributing to beta cell apoptosis under conditions of lipotoxicity.",
keywords = "Apoptosis, Beta cell, Exendin-4, JNK, p53, p66<sup>Shc</sup>, Palmitic acid, Pancreatic islet",
author = "Annalisa Natalicchio and Federica Tortosa and Rossella Labarbuta and Giuseppina Biondi and Nicola Marrano and Emanuele Carchia and Anna Leonardini and Angelo Cignarelli and Marco Bugliani and Piero Marchetti and Fadini, {Gian Paolo} and Marco Giorgio and Angelo Avogaro and Sebastio Perrini and Luigi Laviola and Francesco Giorgino",
year = "2015",
month = "6",
day = "1",
doi = "10.1007/s00125-015-3563-2",
language = "English",
volume = "58",
pages = "1260--1271",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells

AU - Natalicchio, Annalisa

AU - Tortosa, Federica

AU - Labarbuta, Rossella

AU - Biondi, Giuseppina

AU - Marrano, Nicola

AU - Carchia, Emanuele

AU - Leonardini, Anna

AU - Cignarelli, Angelo

AU - Bugliani, Marco

AU - Marchetti, Piero

AU - Fadini, Gian Paolo

AU - Giorgio, Marco

AU - Avogaro, Angelo

AU - Perrini, Sebastio

AU - Laviola, Luigi

AU - Giorgino, Francesco

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Aims/hypothesis: The role of the redox adaptor protein p66Shc as a potential mediator of saturated fatty acid (FA)-induced beta cell death was investigated. Methods: The effects of the FA palmitate on p66Shc expression were evaluated in human and murine islets and in rat insulin-secreting INS-1E cells. p66Shc expression was also measured in islets from mice fed a high-fat diet (HFD) and from human donors with different BMIs. Cell apoptosis was quantified by two independent assays. The role of p66Shc was investigated using pancreatic islets from p66Shc−/− mice and in INS-1E cells with knockdown of p66Shc or overexpression of wild-type and phosphorylation-defective p66Shc. Production of reactive oxygen species (ROS) was evaluated by the dihydroethidium oxidation method. Results: Palmitate induced a selective increase in p66Shc protein expression and phosphorylation on Ser36 and augmented apoptosis in human and mouse islets and in INS-1E cells. Inhibiting the tumour suppressor protein p53 prevented both the palmitate-induced increase in p66Shc expression and beta cell apoptosis. Palmitate-induced apoptosis was abrogated in islets from p66Shc−/− mice and following p66Shc knockdown in INS-1E cells; by contrast, overexpression of p66Shc, but not that of the phosphorylation-defective p66Shc mutant, enhanced palmitate-induced apoptosis. The pro-apoptotic effects of p66Shc were dependent upon its c-Jun N-terminal kinase-mediated phosphorylation on Ser36 and associated with generation of ROS. p66Shc protein expression and function were also elevated in islets from HFD-fed mice and from obese/overweight cadaveric human donors. Conclusions/interpretation: p53-dependent augmentation of p66Shc expression and function represents a key signalling response contributing to beta cell apoptosis under conditions of lipotoxicity.

AB - Aims/hypothesis: The role of the redox adaptor protein p66Shc as a potential mediator of saturated fatty acid (FA)-induced beta cell death was investigated. Methods: The effects of the FA palmitate on p66Shc expression were evaluated in human and murine islets and in rat insulin-secreting INS-1E cells. p66Shc expression was also measured in islets from mice fed a high-fat diet (HFD) and from human donors with different BMIs. Cell apoptosis was quantified by two independent assays. The role of p66Shc was investigated using pancreatic islets from p66Shc−/− mice and in INS-1E cells with knockdown of p66Shc or overexpression of wild-type and phosphorylation-defective p66Shc. Production of reactive oxygen species (ROS) was evaluated by the dihydroethidium oxidation method. Results: Palmitate induced a selective increase in p66Shc protein expression and phosphorylation on Ser36 and augmented apoptosis in human and mouse islets and in INS-1E cells. Inhibiting the tumour suppressor protein p53 prevented both the palmitate-induced increase in p66Shc expression and beta cell apoptosis. Palmitate-induced apoptosis was abrogated in islets from p66Shc−/− mice and following p66Shc knockdown in INS-1E cells; by contrast, overexpression of p66Shc, but not that of the phosphorylation-defective p66Shc mutant, enhanced palmitate-induced apoptosis. The pro-apoptotic effects of p66Shc were dependent upon its c-Jun N-terminal kinase-mediated phosphorylation on Ser36 and associated with generation of ROS. p66Shc protein expression and function were also elevated in islets from HFD-fed mice and from obese/overweight cadaveric human donors. Conclusions/interpretation: p53-dependent augmentation of p66Shc expression and function represents a key signalling response contributing to beta cell apoptosis under conditions of lipotoxicity.

KW - Apoptosis

KW - Beta cell

KW - Exendin-4

KW - JNK

KW - p53

KW - p66<sup>Shc</sup>

KW - Palmitic acid

KW - Pancreatic islet

UR - http://www.scopus.com/inward/record.url?scp=84939942881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939942881&partnerID=8YFLogxK

U2 - 10.1007/s00125-015-3563-2

DO - 10.1007/s00125-015-3563-2

M3 - Article

C2 - 25810038

AN - SCOPUS:84939942881

VL - 58

SP - 1260

EP - 1271

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 6

ER -